iZumi raises $20 million for stem-cell development
iZumi Bio, a company specializing in stem-cell research used to create a range of treatments, has landed $20 million in first-round funding and a partnership with Kyoto University in Japan to conduct parallel studies and collaborate on the results.
One of the company’s primary investors is Kleiner Perkins Caufield & Byers, a firm that has been vocal in its support of stem-cell based therapies for Parkinson’s disease, diabetes and muscular dystrophy. Former vice president and Kleiner… Continue Reading
Digg beefs up its funding for major expansion plans
With over 30 million monthly unique users, Digg is a juggernaut of a site. Despite perpetual rumors of an imminent acquisition by major players like Google or Microsoft, the social voting site is now gearing up for a major expansion on its own. And it’s just secured a big round of funding to make that expansion possible.
Interestingly, almost half of Digg’s users are outside of the U.S. now, the service claims on its blog. So… Continue Reading